MeSH tree: D20.215.894.865.450.250
Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
Jul 8, 2025
0
0
Until recently, human vaccine development has typically taken 10 to 15 years.
Nov 29, 2024
0
0
COVID-19 vaccination seems to have some side effects on the lower urinary tract and overactive bladder in younger adults, according to a study published online June 24 in Frontiers in Medicine.
Aug 1, 2024
0
36
The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7, 2024, the European Commission announced the vaccine is no longer authorized for use.
May 9, 2024
0
14
Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing COVID vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.
May 8, 2024
0
0
A study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
May 3, 2024
0
56
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit worth potentially $125 ...
May 1, 2024
0
4
In Brazil, researchers at the University of São Paulo (USP) and the Pernambuco division of Oswaldo Cruz Foundation (FIOCRUZ) are developing a Zika vaccine. The formulation was tested on mice and found to be efficacious, ...
Apr 18, 2024
0
28
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID.
Jan 12, 2024
0
1
A large international research collaboration, led by an academic from Royal Holloway, University of London, found that blood groups could help predict the risk of venous strokes associated with the Oxford-AstraZeneca COVID-19 ...
Dec 14, 2023
0
25
